Provider review
Medro review
Blocked every fetch this pass; a search turned up almost no independent coverage at all
Medro (Medro Health Technologies, Inc.) markets compounded semaglutide and tirzepatide with prices reportedly dropping on longer commitments — semaglutide to $149/mo and tirzepatide to $224/mo on a 12-month plan, per prior research not independently reconfirmed live this pass, since getmedro.com returned HTTP 403 to every fetch attempt tried, including specific sub-paths. A broader web search for independent coverage — reviews, press, comparison-site mentions — turned up essentially nothing, in contrast to competing providers that surface easily in the same searches. This is consistent with prior research describing Medro as a very new brand launched in 2026 with a trademark still pending, and corroborates rather than contradicts that characterization, even though this pass couldn't verify pricing or state-coverage claims directly.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Medro is the hardest provider on this list to independently size up: the site blocked every fetch attempt this pass, and a broader search for outside coverage came back almost empty, which is itself informative for a brand prior research already flagged as very new. Prior research described LegitScript certification, all-50-state coverage, and price-drops on longer commitments — none of that could be reconfirmed live here, so treat those specifics as provisional until you can verify them yourself, ideally by loading the site directly in a browser rather than relying on this review alone.
Medro is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You're comfortable being an early adopter of a newly launched 2026 brand with a thin track record
- You want to independently verify pricing and state coverage yourself before committing, given this review couldn't
- You've confirmed the specific LegitScript seal number directly rather than trusting a badge image alone
Look elsewhere if
- You want a provider with an established, independently verifiable track record
- You need to research a provider before committing — this site blocked every automated fetch attempt this pass
- You want a named compounding pharmacy or clinical partner medical group — neither is disclosed per prior research
What it actually costs
What they advertise
Pricing not published live on this pass — the site blocked every fetch attempt; prior research described tiered pricing shown before checkout.
What you actually pay, month to month
Pricing not published live on this pass; prior research described semaglutide dropping to $149/mo and tirzepatide to $224/mo on a 12-month plan, not independently reconfirmed.
We checked Medro's own public pages in August 2026 and found no dollar figure. We do not print a number we cannot see, and we do not repeat one from a third-party blog. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Medro bundles in, and what it does not.
Clinician consult
Not independently reconfirmed live this pass; per prior…
research, online intake with no appointment required in many cases.
Bloodwork / labs
Not addressed in the sources read.
Follow-ups and dose changes
Not addressed with a specific cadence in the sources read.
Human support
Not addressed with specifics in the sources read.
Injection supplies
Not itemized in the sources read.
Shipping
Free expedited shipping referenced in prior research, not…
independently reconfirmed live.
Pharmacy, labs and oversight
The pharmacy
Not named per prior research; not independently reconfirmed this pass, site blocked every fetch attempt.
Oversight
Not independently reconfirmed live this pass; per prior research, online intake with no appointment required in many cases. Not addressed with a specific cadence in the sources read.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Prior research recorded all 50 states; not independently reconfirmed live this pass, site blocked every fetch attempt.
The honest cons
The part they would rather you skipped
Medro's own site returned HTTP 403 to every fetch attempt this pass, and a broader search for independent coverage — reviews, press, any comparison-site mention — turned up almost nothing, consistent with a very new, thinly established brand worth researching further yourself before committing.
- Site blocked every fetch attempt this pass; pricing and coverage claims rest entirely on prior research
- Essentially no independent web footprint found — no reviews, press, or third-party coverage surfaced
- Compounding pharmacy and clinical partner medical group not disclosed per prior research
- Very new brand (2026 launch, trademark pending) with a short track record
None of this is unique to Medro — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that board ranks them. Medro is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- BHBodybuilding Health+One of the deepest peptide catalogues here, and the loosest one
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Direct MedsThe plainest price mechanics on either board, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
7 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Medro's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Medro's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.